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I. Introduction 
In the course of our investigations on structure- 
activity correlations of analogues of antamanide (I) 
[ 1,2] , an antitoxic principle from the toadstool 
Amanita phalloides [3] , we have also synthesized 
4phe-6Val-antamanide (II). 
Pro-Phe-Phe-VkF’ro Pro-Phe-Phe-Vk-Pro 
t 4 
Pro-Pze-Phe-Alfa-Pro 
t 4 
Pro-Val-Phe-Phe-Pro 
I II 
The cyclopeptide II, in contrast to I, has C2 
symmetry and was expected to lend itself to a less 
difficult structure analysis than I. However, cyclo- 
peptide II is of interest only if it also has antitoxic 
activity against phallotoxins. It is also possible to ob- 
tain an achiral cyclodecapeptide by substitution in I 
of lVa1 by Ala and an exchange of amino acid 4 + 6. 
However, the ‘Ala variant of I previously proved less 
than 5% as active as I, whereas substitution of 4Ala 
by Val resulted in practically no loss of activity [3] . 
2. Materials and methods 
The cyclodecapeptide 11 was synthesized by 
dimerizing cyclization of the pentapeptide Ill, 
Val-Pro-Pro-Phe-Phe, using the p-nitrophenylester 
of Ill [4] or dicylclohexylcarbodiimide (DCCI) [5] 
and hydroxysuccinimide [6]. Both methods gave 
only poor yields of II, and in addition the monomeric 
* Part VIII of a series. Previous communication ref. [ 1 ] 
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cyclization product IV, cycle-Val-Pro-Pro-Phe-Phe. 
Pentapeptide Ill was built up by stepwise condensa- 
tion with DCCI on a solid phase from Boc-amino acids 
according to Merrifield [7] using an automated Pep- 
tide Synthesizer (Schwarz, BioResearch [ 11). 10 g 
polymer, esterified with 1.57 mmoles/g Boc-Phe , was 
treated according to [l] successively with Boc-Phe, where 
Boc-Pro, Boc-Pro, and Boc-Val to give 15 g Boc- 
pentapeptide polymer. The Boc-derivative of Ill was 
removed from the resin by transesterification with 
500 ml methanol, containing 58 g of ethyldiiso- 
propylamine [8]. The methylester Boc-Val-Pro- 
Pro-Phe-Phe-OMe (TLC on silica gel R,f 0.82 in 
chloroform-methanol-water (65:25:4), two slower 
moving impurities) was saponified in 20 ml dimethyl- 
formamide by adding 1 N aqueous NaOH at pH 10.9 
in an autotitrator. After addition of 40 ml Hz0 and 
acidification with citric acid, the Boc-pentapeptide 
was extracted into ethylacetate and, after HzO- 
washing, drying the solution and evaporation in vacua, 
was obtained as a solid of 4.9 g (44.3%), Rf 0.57. 
amino acid analysis: Val,,O Pro2.D5 Phe,,. 
The nitrophenylester of pentapeptide Ill was 
obtained from 2.45 g of the Boc-pentapeptide and 
1.85 g p-nitrophenol in 20 ml ethylacetate with 0.789 
g DCCI at -10” for 3 hr and 20” for further 15 hr, 
filtering off the dicyclohexylurea formed. and evapora- 
tion in vacua; Rf 0.60 (+ traces of the urea). In order 
to remove the Boc-residue, the substance was stirred 
in 45 ml trifluoroacetic acid (TFA) at 20” for 4 hr, 
and after evaporation in vacua. dissolved in 20 ml dry 
tetrahydrofurdne and precipitated by adding 100 ml 
of ether. Purification by chromatography on 
Sephadex LH-20 (5 X 180 cm) with methanol as a 
solvent yielded 1.9 g (65%) of the TFA salt of 
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Val-Phe-Phe-Pro-Pro-OPNP; Rf 0.7 1 (t 2 weak position, m/e = 587 and no protecting action at doses 
spots of slower moving impurities). as high as 20 mg per kg. 
Dimerizing cyclization 
a) p-Nitrophenylester [4] . 1.9 g of the TFA salt of 
Val-Pro-Pro-Phe-Phe-OPNP was dissolved in 20 
ml dimethylformamide and slowly added to 430 ml 
pyridine at 55”. After standing for further 3 hr at 55” 
and overnight at 20”) the mixture was evaporated, dis- 
solved in methylenechloride, excess p-nitrophenol 
extracted with NaHCO, solution and the dried residue 
chromatographed on Sephadex LH-20 (5 X 180 cm) 
with methanol as solvent: the yield obtained was 40 
mg of II as first and 27 mg of IV as second fraction. 
The optical rotatory dispersion (ORD) curve of II 
has a different shape in methanol or in dioxane 
respectively, similarly to antamanide [9] . In a study 
of several 1,4 substituted analogues [2] Lapatsanis 
observed a parallelism between the maximal negative 
rotatory value in dioxane at 240 nm and the antitoxic 
activity e.g. antamanide (I) showing [M] = -8.5 X lo4 
and the inert 1Gly4Gly-analogue showing [M] = 
-2.0 X 104 [lo] . The new analogue II had [M] = 
-8.7 X 104 ; it also shows affinity for Na ions as 
apparent from ORD curves with and without Na+ in 
methanol similarly to antamanide [9] . 
b) 2.43 g Boc-derivative of III was treated with 30 
ml TFA for 2 hr at 20”. The TFA-salt of III (Rf 0.41, 
single spot) obtained after evaporation was subjected 
to cyclization as described for a decapeptide in [6] . 
After chromatography as in a) 38 mg of II and 78 mg 
of IV were obtained. 
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